On the public citation graph

Drug repositioning in cancer: The current situation in Japan

0 signed · 111 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 67 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1073/pnas.1417273112 (notice 2021-11-02).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cncr.11128openalex-snapshot
Antitumor effects of bisphosphonates
inferredcites →https://doi.org/10.1002/ijc.29881openalex-snapshot
Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status
inferredcites →https://doi.org/10.1007/978-1-4939-8868-6_15openalex-snapshot
In Silico Oncology Drug Repositioning and Polypharmacology
inferredcites →https://doi.org/10.1007/s00018-019-03134-0openalex-snapshot
Drug repurposing to overcome resistance to various therapies for colorectal cancer
inferredcites →https://doi.org/10.1007/s00535-003-1098-7openalex-snapshot
Propagermanium: a nonspecific immune modulator for chronic hepatitis B
inferredcites →https://doi.org/10.1016/j.bbcan.2019.04.005openalex-snapshot
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
inferredcites →https://doi.org/10.1016/j.bpg.2011.10.016openalex-snapshot
Pharmacology and cellular/molecular mechanisms of action of aspirin and Non-aspirin NSAIDs in colorectal cancer
inferredcites →https://doi.org/10.1016/j.canlet.2005.03.024openalex-snapshot
Vessel dilator: Most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells
inferredcites →https://doi.org/10.1016/j.cmet.2010.03.014openalex-snapshot
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
inferredcites →https://doi.org/10.1016/j.drudis.2012.07.014openalex-snapshot
Transcriptional data: a new gateway to drug repositioning?
inferredcites →https://doi.org/10.1016/j.drudis.2012.08.005openalex-snapshot
In silico drug repositioning – what we need to know
inferredcites →https://doi.org/10.1016/j.drudis.2015.05.001openalex-snapshot
Drug repositioning and repurposing: terminology and definitions in literature
inferredcites →https://doi.org/10.1016/j.drudis.2016.09.019openalex-snapshot
Design of efficient computational workflows for in silico drug repurposing
inferredcites →https://doi.org/10.1016/j.ejphar.2018.04.023openalex-snapshot
Old wines in new bottles: Repurposing opportunities for Parkinson's disease
inferredcites →https://doi.org/10.1016/j.semcancer.2019.09.020openalex-snapshot
Systems biology based drug repositioning for development of cancer therapy
inferredcites →https://doi.org/10.1016/j.semcancer.2019.09.023openalex-snapshot
Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets
inferredcites →https://doi.org/10.1016/j.tim.2018.04.004openalex-snapshot
Drug Repurposing for Viral Infectious Diseases: How Far Are We?
inferredcites →https://doi.org/10.1016/s0140-6736(96)07424-7openalex-snapshot
The natriuretic-peptide family
inferredcites →https://doi.org/10.1038/448645aopenalex-snapshot
New uses for old drugs
inferredcites →https://doi.org/10.1038/534314aopenalex-snapshot
Can you teach old drugs new tricks?
inferredcites →https://doi.org/10.1038/nbt.2786openalex-snapshot
Clinical development success rates for investigational drugs
inferredcites →https://doi.org/10.1038/nbt0712-571aopenalex-snapshot
NCATS launches drug repurposing program
inferredcites →https://doi.org/10.1038/ng.2734openalex-snapshot
The integrated landscape of driver genomic alterations in glioblastoma
inferredcites →https://doi.org/10.1038/nrd1468openalex-snapshot
Drug repositioning: identifying and developing new uses for existing drugs
inferredcites →https://doi.org/10.1038/nrd3078openalex-snapshot
How to improve R&D productivity: the pharmaceutical industry's grand challenge
inferredcites →https://doi.org/10.1038/nrd3913openalex-snapshot
Objective assessment of cancer genes for drug discovery
inferredcites →https://doi.org/10.1038/srep40164openalex-snapshot
Elucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics
inferredcites →https://doi.org/10.1046/j.1365-2362.2003.01262.xopenalex-snapshot
Four peptides decrease the number of human pancreatic adenocarcinoma cells
inferredcites →https://doi.org/10.1056/nejm199807303390507openalex-snapshot
Natriuretic Peptides
inferredcites →https://doi.org/10.1056/nejmra052717openalex-snapshot
Low-Dose Aspirin for the Prevention of Atherothrombosis
inferredcites →https://doi.org/10.1073/pnas.1417273112openalex-snapshot
RETRACTED: Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells
inferredcites →https://doi.org/10.1089/107999001750277862openalex-snapshot
An Anti-Inflammatory Drug, Propagermanium, May Target GPI-Anchored Proteins Associated with an MCP-1 Receptor, CCR2
inferredcites →https://doi.org/10.1093/bioinformatics/btq176openalex-snapshot
Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework
inferredcites →https://doi.org/10.1111/cas.13849openalex-snapshot
Novel application of metformin combined with targeted drugs on anticancer treatment
inferredcites →https://doi.org/10.1111/cas.14075openalex-snapshot
Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
inferredcites →https://doi.org/10.1111/cas.14149openalex-snapshot
Chemoprevention of colorectal cancer: Past, present, and future
inferredcites →https://doi.org/10.1111/cas.14306openalex-snapshot
Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
inferredcites →https://doi.org/10.1111/cas.14318openalex-snapshot
Drug repositioning in cancer: The current situation in Japan
inferredcites →https://doi.org/10.1111/epi.13994openalex-snapshot
The prescribable drugs with efficacy in experimental epilepsies ( PDE 3) database for drug repurposing research in epilepsy
inferredcites →https://doi.org/10.1111/j.1365-2362.2004.01402.xopenalex-snapshot
Novel therapeutic approach for cancer using four cardiovascular hormones
inferredcites →https://doi.org/10.1111/j.1365-2362.2005.01444.xopenalex-snapshot
Four peptide hormones decrease the number of human breast adenocarcinoma cells
inferredcites →https://doi.org/10.1111/j.1365-2362.2005.01501.xopenalex-snapshot
Five cardiac hormones decrease the number of human small‐cell lung cancer cells
inferredcites →https://doi.org/10.1111/j.1365-2362.2006.01721.xopenalex-snapshot
Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers
inferredcites →https://doi.org/10.1111/jcpt.12759openalex-snapshot
Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
inferredcites →https://doi.org/10.1126/science.1132939openalex-snapshot
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
inferredcites →https://doi.org/10.1126/scitranslmed.3001318openalex-snapshot
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
inferredcites →https://doi.org/10.1126/scitranslmed.3001862openalex-snapshot
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
inferredcites →https://doi.org/10.1126/scitranslmed.3002648openalex-snapshot
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
inferredcites →https://doi.org/10.1172/jci78782openalex-snapshot
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner
inferredcites →https://doi.org/10.1183/16000617.0098-2017openalex-snapshot
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
inferredcites →https://doi.org/10.1186/s13046-017-0642-xopenalex-snapshot
Drug repurposing for the treatment of glioblastoma multiforme
inferredcites →https://doi.org/10.1186/s13063-017-1928-1openalex-snapshot
A multicenter randomized controlled trial of surgery alone or surgery with atrial natriuretic peptide in lung cancer surgery: study protocol for a randomized controlled trial
inferredcites →https://doi.org/10.1385/ijgc:36:2:77openalex-snapshot
Four Peptides Decrease Human Colon Adenocarcinoma Cell Number and DNA Synthesis via Cyclic GMP
inferredcites →https://doi.org/10.18632/aging.101135openalex-snapshot
Biocomputing drug repurposing toward targeted therapies
inferredcites →https://doi.org/10.2165/00003495-200464110-00004openalex-snapshot
Zoledronic Acid
inferredcites →https://doi.org/10.2174/1381612033453640openalex-snapshot
New Insights Into the Molecular Mechanisms of Action of Bisphosphonates
inferredcites →https://doi.org/10.21873/anticanres.13651openalex-snapshot
Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory Cancer
inferredcites →https://doi.org/10.2310/jim.0b013e3181948b25openalex-snapshot
Cardiac and Renal Hormones
inferredcites →https://doi.org/10.3332/ecancer.2014.442openalex-snapshot
ecancermedicalscience
inferredcites →https://doi.org/10.3332/ecancer.2014.485openalex-snapshot
Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent
inferredcites →https://doi.org/10.3332/ecancer.2016.610openalex-snapshot
Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
inferredcites →https://doi.org/10.3332/ecancer.2018.886openalex-snapshot
ReDO_DB: the repurposing drugs in oncology database
inferredcites →https://doi.org/10.3389/fphar.2017.00729openalex-snapshot
Overcoming Obstacles to Drug Repositioning in Japan
inferredcites →https://doi.org/10.3389/fphys.2018.00500openalex-snapshot
Drug Repositioning for Effective Prostate Cancer Treatment
inferredcites →https://doi.org/10.3390/cancers8070066openalex-snapshot
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
inferredcites →https://doi.org/10.4161/cc.8.6.7933openalex-snapshot
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
inferredcites →https://doi.org/10.7150/ijbs.9224openalex-snapshot
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/bab.2150openalex-snapshot
A comprehensive review on anticancer mechanism of bazedoxifene
inferred← citeshttps://doi.org/10.1007/978-981-16-9232-1_8openalex-snapshot
Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatment
inferred← citeshttps://doi.org/10.1007/s00210-025-04508-xopenalex-snapshot
Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck
inferred← citeshttps://doi.org/10.1007/s00396-024-05283-6openalex-snapshot
Box-Behnken design based optimization of polyvinylpyrrolidone stabilized valproic acid nanoemulsion and evaluation of its anticancer potential
inferred← citeshttps://doi.org/10.1007/s00432-024-05741-2openalex-snapshot
Promising anticancer activity of cromolyn in colon cancer: in vitro and in vivo analysis
inferred← citeshttps://doi.org/10.1007/s00592-024-02344-8openalex-snapshot
SGLT-2 inhibitors are beneficial in reducing the risk of thyroid cancer: findings from a Mendelian randomization study
inferred← citeshttps://doi.org/10.1007/s00595-021-02273-xopenalex-snapshot
Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence
inferred← citeshttps://doi.org/10.1007/s40199-025-00562-1openalex-snapshot
Drug repositioning: examining antipsychotic drugs and their anticancer effects
inferred← citeshttps://doi.org/10.1016/b978-0-443-16013-4.00014-2openalex-snapshot
Reverse pharmacology and drug repositioning in drug discovery
inferred← citeshttps://doi.org/10.1016/j.csbj.2021.08.003openalex-snapshot
A data-driven methodology towards evaluating the potential of drug repurposing hypotheses
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.103396openalex-snapshot
Advancing drug repurposing research: Trends, collaborative networks, innovation and knowledge leaders
inferred← citeshttps://doi.org/10.1016/j.drup.2020.100713openalex-snapshot
Repurposing old drugs to fight multidrug resistant cancers
inferred← citeshttps://doi.org/10.1016/j.patter.2022.100470openalex-snapshot
Artificial intelligence-assisted drug repurposing via “chemical-induced gene expression ranking”
inferred← citeshttps://doi.org/10.1039/d4ra07581aopenalex-snapshot
Repurposing of Indomethacin and Naproxen as anticancer agents: progress from 2017 to present
inferred← citeshttps://doi.org/10.1093/bib/bbad142openalex-snapshot
Decoding Connectivity Map-based drug repurposing for oncotherapy
inferred← citeshttps://doi.org/10.1097/cad.0000000000001098openalex-snapshot
Repurposing calcium channel blockers: may be sensible combination with erlotinib for non-small cell lung cancer
inferred← citeshttps://doi.org/10.1097/ms9.0000000000003043openalex-snapshot
Chemotherapy with a molecular rational basis, pentoxifylline as a promising antitumor drug
inferred← citeshttps://doi.org/10.1101/2021.10.14.464376openalex-snapshot
Identification of antineoplastic agents for oral squamous cell carcinoma: an integrated bioinformatics approach using differential gene expression and network biology
inferred← citeshttps://doi.org/10.1111/cas.14858openalex-snapshot
The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer
inferred← citeshttps://doi.org/10.1111/cas.15502openalex-snapshot
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast
inferred← citeshttps://doi.org/10.1111/hepr.70135openalex-snapshot
Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1186/s13063-021-05273-xopenalex-snapshot
Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
inferred← citeshttps://doi.org/10.2174/0113816128304230240327044201openalex-snapshot
Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates
inferred← citeshttps://doi.org/10.2174/0115665240344867241021043636openalex-snapshot
Ionizing Radiation Combined with Gold Complex Compounds Causes Apoptosis in Colorectal Cancer Cells by Increasing the Level of Caspase-3
inferred← citeshttps://doi.org/10.2174/0115701638253929230922115127openalex-snapshot
Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs
inferred← citeshttps://doi.org/10.2174/1568026623666230130150029openalex-snapshot
Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment
inferred← citeshttps://doi.org/10.2174/1871520622666220317140557openalex-snapshot
Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
inferred← citeshttps://doi.org/10.21873/anticanres.15237openalex-snapshot
Lurasidone Sensitizes Cancer Cells to Osimertinib by Inducing Autophagy and Reduction of Survivin
inferred← citeshttps://doi.org/10.21873/invivo.12625openalex-snapshot
Leukotriene Receptor Antagonist Use and Dementia Risk in Patients With Asthma: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.3389/fphar.2023.1303844openalex-snapshot
Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
inferred← citeshttps://doi.org/10.3390/biomedicines11061535openalex-snapshot
Physiological Activity of Trace Element Germanium Including Anticancer Properties
inferred← citeshttps://doi.org/10.3390/ijms22147444openalex-snapshot
Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
inferred← citeshttps://doi.org/10.3390/ijms241612997openalex-snapshot
Drug Repositioning for Refractory Benign Tumors of the Central Nervous System
inferred← citeshttps://doi.org/10.3390/medicina59122059openalex-snapshot
Gramicidin, a Bactericidal Antibiotic, Is an Antiproliferative Agent for Ovarian Cancer Cells
inferred← citeshttps://doi.org/10.3390/molecules25173933openalex-snapshot
Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast Cancer
inferred← citeshttps://doi.org/10.3390/molecules29143379openalex-snapshot
Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression
inferred← citeshttps://doi.org/10.3390/ph15020124openalex-snapshot
Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer
inferred← citeshttps://doi.org/10.3390/ph17101394openalex-snapshot
Auranofin as a Novel Anticancer Drug for Anaplastic Thyroid Cancer
inferred← citeshttps://doi.org/10.34248/bsengineering.1537989openalex-snapshot
In Silico Prediction of EGFR Inhibitors from Thiophene Derivatives
inferred← citeshttps://doi.org/10.3892/or.2024.8833openalex-snapshot
Repurposing the antipsychotic drug penfluridol for cancer treatment (Review)
inferred← citeshttps://doi.org/10.3999/jscpt.52.44openalex-snapshot
1. An Integrative Omics Approach to Drug Discovery
inferred← citeshttps://doi.org/10.4328/acam.21190openalex-snapshot
Calcium Channel Blockers Increase Sunitinib Effectiveness in Metastatic Renal Cell Carcinoma Treatment
inferred← citeshttps://doi.org/10.5772/intechopen.110105openalex-snapshot
Role of Drug Repurposing in Cancer Treatment and Liposomal Approach of Drug Targeting
showing the first 43 of 44 · page through all 44
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.